Correlation Between Bio Path and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Path and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and NextCure, you can compare the effects of market volatilities on Bio Path and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and NextCure.

Diversification Opportunities for Bio Path and NextCure

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bio and NextCure is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Bio Path i.e., Bio Path and NextCure go up and down completely randomly.

Pair Corralation between Bio Path and NextCure

Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the NextCure. In addition to that, Bio Path is 2.09 times more volatile than NextCure. It trades about -0.07 of its total potential returns per unit of risk. NextCure is currently generating about 0.0 per unit of volatility. If you would invest  177.00  in NextCure on August 31, 2024 and sell it today you would lose (60.00) from holding NextCure or give up 33.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bio Path Holdings  vs.  NextCure

 Performance 
       Timeline  
Bio Path Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Bio Path and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Path and NextCure

The main advantage of trading using opposite Bio Path and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Bio Path Holdings and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance